Early intervention in psychosis

Last updated

Early intervention in psychosis is a clinical approach to those experiencing symptoms of psychosis for the first time. It forms part of a new prevention paradigm for psychiatry [1] [2] and is leading to reform of mental health services, [3] especially in the United Kingdom [4] [5] and Australia.

Contents

This approach centers on the early detection and treatment of early symptoms of psychosis during the formative years of the psychotic condition. The first three to five years are believed by some to be a critical period. [6] The aim is to reduce the usual delays to treatment for those in their first episode of psychosis. The provision of optimal treatments in these early years is thought to prevent relapses and reduce the long-term impact of the condition. It is considered a secondary prevention strategy.

The duration of untreated psychosis (DUP) has been shown as an indicator of prognosis, with a longer DUP associated with more long-term disability. [7]

Components of the model

There are a number of functional components of the early psychosis model, [8] [9] [10] and they can be structured as different sub-teams within early psychosis services. The emerging pattern of sub-teams are currently:

Early psychosis treatment teams

Multidisciplinary clinical teams providing an intensive case management approach for the first three to five years. The approach is similar to assertive community treatment, but with an increased focus on the engagement and treatment of this previously untreated population and the provision of evidence based, optimal interventions for clients in their first episode of psychosis. For example, the use of low-dose antipsychotic medication is promoted ("start low, go slow"), with a need for monitoring of side effects and an intensive and deliberate period of psycho-education for patients and families that are new to the mental health system. In addition, research showed that family intervention for psychosis (FIp) reduced relapse rates, hospitalization duration, and psychotic symptoms along with increasing functionality in first-episode psychosis (FEP) up to 24 months. [11] Interventions to prevent a further episodes of psychosis (a "relapse") and strategies that encourage a return to normal vocation and social activity are a priority. There is a concept of phase specific treatment for acute, early recovery and late recovery periods in the first episode of psychosis.

Early detection function

Interventions aimed at avoiding late detection and engagement of those in the course of their psychotic conditions. [12] Key tasks include being aware of early signs of psychosis and improving pathways into treatment. [13] Teams provide information and education to the general public and assist GPs with recognition and response to those with suspected signs, for example: EPPIC's [14] Youth Access Team (YAT) [15] (Melbourne); OPUS [16] (Denmark); TIPS [17] (Norway); REDIRECT [18] (Birmingham); LEO CAT (London) [19] "; STEP's Population Health approach to early detection. [20] [21]

The development and implementation of quantitative tools for early detection of at-risk individuals is an active research area. This includes development of risk calculators [22] and methods for large-scale population screening. [23]

Prodrome clinics

Prodrome or at risk mental state clinics are specialist services for those with subclinical symptoms of psychosis or other indicators of risk of transition to psychosis. The Pace Clinic [24] in Melbourne, Australia, is considered one of the origins of this strategy, [25] but a number of other services and research centers have since developed. [26] [27] These services are able to reliably identify those at high risk of developing psychosis [28] and are beginning to publish encouraging outcomes from randomised controlled trials that reduce the chances of becoming psychotic, [29] including evidence that psychological therapy [30] and high doses of fish oil [31] have a role in the prevention of psychosis. However, a meta-analysis of five trials found that while these interventions reduced risk of psychosis after 1 year (11% conversion to psychosis in intervention groups compared to 32% in control groups), these gains were not maintained over 2–3 years of follow-up. [32] These findings indicate that interventions delay psychosis, but do not reduce the long-term risk. There has also been debate about the ethics of using antipsychotic medication to reduce the risk of developing psychosis, because of the potential harms involved with these medications. [33]

In 2015, the European Psychiatric Association issued guidance recommending the use of the Cognitive Disturbances scale (COGDIS), a subscale of the basic symptoms scale, to assess psychosis risk; a meta-analysis conducted for the guidance found that while rates of conversion to psychosis were similar to those who meet Ultra High Risk (UHR) criteria up to 2 years after assessment, they were significantly higher after 2 years for those patients who met the COGDIS criteria. [34] The COGDIS criteria measure subjective symptoms, and include such symptoms as thought interference, where irrelevant and emotionally unimportant thought contents interfere with the main line of thinking; thought block, where the current train of thought halts; thought pressure, where thoughts unrelated to a common topic appear uncontrollably; referential ideation that is immediately corrected; and other characteristic disturbances of attention and the use or understanding of language.

History

Early intervention in psychosis is a preventive approach for psychosis that has evolved as contemporary recovery views of psychosis and schizophrenia have gained acceptance. It subscribes to a "post Kraepelin" concept of schizophrenia, challenging the assumptions originally promoted by Emil Kraepelin in the 19th century, that schizophrenia ("dementia praecox") was a condition with a progressing and deteriorating course. The work of Post, whose kindling model, together with Fava and Kellner, who first adapted staging models to mental health, provided an intellectual foundation. Psychosis is now formulated within a diathesis–stress model, allowing a more hopeful view of prognosis, and expects full recovery for those with early emerging psychotic symptoms. It is more aligned with psychosis as continuum (such as with the concept of schizotypy) with multiple contributing factors, rather than schizophrenia as simply a neurobiological disease.

Within this changing view of psychosis and schizophrenia, the model has developed from a divergence of several different ideas, and from a number of sites, beginning with the closure of psychiatric institutions signaling a move toward community based care. [35] In 1986, the Northwick Park study [36] discovered an association between delays to treatment and disability, questioning the service provision for those with their first episode of schizophrenia. In the 1990s, evidence began to emerge that cognitive behavioural therapy was an effective treatment for delusions and hallucinations. [37] [38] [39] The next step came with the development of the EPPIC early detection service in Melbourne, Australia in 1996 [14] and the prodrome clinic led by Alison Yung. This service was an inspiration to other services, such as the West Midlands IRIS group, including the carer charity Rethink Mental Illness; the TIPS early detection randomised control trial in Norway; [17] and the Danish OPUS trial. [16] In 2001, the United Kingdom Department of Health called the development of early psychosis teams "a priority". [40] The International Early Psychosis Association, founded in 1998, issued an international consensus declaration together with the World Health Organization in 2004. [41] [42] Clinical practice guidelines have been written by consensus. [9]

Evidence

Clinical outcomes

There is evidence that providing access to specialized early intervention services results in benefits to patients during treatment. Such services lead to higher satisfaction among patients, and patients who have access to specialized early intervention services are more likely to stay in treatment, according to a 2020 Cochrane review. The same review also found that early intervention improved long-term global functioning outcomes; however, the evidence for this conclusion was of a lower quality, and all studies included in the review had been conducted in high-income countries, so it is not clear how these result will translate to lower-income countries. It is also unclear whether the benefits derived from early intervention persist once the patient is transferred to non-specialized treatment. [43]

Cost-effectiveness

One argument in favor of creating early intervention services is that they not only improve clinical outcomes for individual patients, but also cost less than standard services to operate, for example by reducing in-patient costs. [44] [45] A systematic review conducted in 2019 concluded that there is evidence to support this claim; however, many of the available studies on the cost-effectiveness of these services have methodological flaws, and it is unclear whether their results will translate to lower-income countries. [46] Another review conducted in 2020 likewise found low-certainty evidence that early intervention reduces the risk of subsequent in-patient hospitalization. [43]

Reform of mental health services

United Kingdom

The United Kingdom has made significant service reform with their adoption of early psychosis teams following the first service in Birmingham set up by Professor Max Birchwood in 1994 and used as a blueprint for national roll-out, with early psychosis now considered as an integral part of comprehensive community mental health services. The Mental Health Policy Implementation Guide outlines service specifications and forms the basis of a newly developed fidelity tool. [40] [47] There is a requirement for services to reduce the duration of untreated psychosis, as this has been shown to be associated with better long-term outcomes. The implementation guideline recommends:

Australia and New Zealand

In Australia the EPPIC initiative provides early intervention services. [48] In the Australian government's 2011 budget, $222.4 million was provided to fund 12 new EPPIC centres in collaboration with the states and territories. [49] However, there have been criticisms of the evidence base for this expansion and of the claimed cost savings. [50] [51] [52]

On August 19, 2011, Patrick McGorry, South Australian Social Inclusion Commissioner David Cappo AO and Frank Quinlan, CEO of the Mental Health Council of Australia, addressed a meeting of the Council of Australian Governments (COAG), chaired by Prime Minister Julia Gillard, on the future direction of mental health policy and the need for priority funding for early intervention. [53] The invitation, an initiative of South Australian Premier Mike Rann, followed the release of Cappo's "Stepping Up" report, supported by the Rann Government, which recommended a major overhaul of mental health in South Australia, including stepped levels of care and early intervention. [54]

New Zealand has operated significant early psychosis teams for more than 20 years, following the inclusion of early psychosis in a mental health policy document in 1997. [55] There is a national early psychosis professional group, New Zealand Early Intervention for Psychosis Society (NZEIPS), [56] organising a biannual training event, advocating for evidenced based service reform and supporting production of local resources.

Scandinavia

Early psychosis programmes have continued to develop from the original TIPS services in Norway. [17] [ needs update ]

In Denmark, an early intervention programme called OPUS was introduced as a randomized trial between 1998 and 2000. [16] The trial was considered successful and OPUS was subsequently made the standard treatment programme for people aged 18–35. Later analysis of the effects of the programme conducted in 2021 showed that it had not only maintained its effects from the first trial, but that it had in fact been even more effective following its nationwide adoption as the standard treatment. [57] [58]

North America

Canada has extensive coverage across most provinces, including established clinical services and comprehensive academic research in British Columbia (Vancouver), Alberta (EPT in Calgary), Quebec (PEPP-Montreal), and Ontario (PEPP, FEPP).

In the United States, the Early Assessment Support Alliance (EASA) is implementing early psychosis intervention throughout the state of Oregon. [59]

In the United States, the implementation of coordinated specialty care (CSC), as a recovery-oriented treatment program for people with first episode psychosis (FEP), has become a US health policy priority. [60] CSC promotes shared decision making and uses a team of specialists who work with the client to create a personal treatment plan. The specialists offer psychotherapy, medication management geared to individuals with FEP, family education and support, case management, and work or education support, depending on the individual's needs and preferences. The client and the team work together to make treatment decisions, involving family members as much as possible. The goal is to link the individual with a CSC team as soon as possible after psychotic symptoms begin [61] because a longer period of unchecked and untreated illness might be associated with poorer outcomes. [62] [63] [64] [65]

Asia

The first meeting of the Asian Network of Early Psychosis (ANEP) was held in 2004. There are now established services in Singapore, [66] Hong Kong [67] and South Korea [68]

See also

Related Research Articles

<span class="mw-page-title-main">Antipsychotic</span> Class of medications

Antipsychotics, previously known as neuroleptics and major tranquilizers, are a class of psychotropic medication primarily used to manage psychosis, principally in schizophrenia but also in a range of other psychotic disorders. They are also the mainstay, together with mood stabilizers, in the treatment of bipolar disorder. Moreover, they are also used as adjuncts in the treatment of treatment-resistant major depressive disorder.

Psychosis is a condition of the mind that results in difficulties determining what is real and what is not real. Symptoms may include delusions and hallucinations, among other features. Additional symptoms are incoherent speech and behavior that is inappropriate for a given situation. There may also be sleep problems, social withdrawal, lack of motivation, and difficulties carrying out daily activities. Psychosis can have serious adverse outcomes.

<span class="mw-page-title-main">Schizophrenia</span> Mental disorder with psychotic symptoms

Schizophrenia is a mental disorder characterized by reoccurring episodes of psychosis that are correlated with a general misperception of reality. Other common signs include hallucinations, delusions, disorganized thinking, social withdrawal, and flat affect. Symptoms develop gradually and typically begin during young adulthood and are never resolved. There is no objective diagnostic test; diagnosis is based on observed behavior, a psychiatric history that includes the person's reported experiences, and reports of others familiar with the person. For a diagnosis of schizophrenia, the described symptoms need to have been present for at least six months or one month. Many people with schizophrenia have other mental disorders, especially substance use disorders, depressive disorders, anxiety disorders, and obsessive–compulsive disorder.

Schizoaffective disorder is a mental disorder characterized by abnormal thought processes and an unstable mood. This diagnosis requires symptoms of both schizophrenia and a mood disorder: either bipolar disorder or depression. The main criterion is the presence of psychotic symptoms for at least two weeks without any mood symptoms. Schizoaffective disorder can often be misdiagnosed when the correct diagnosis may be psychotic depression, bipolar I disorder, schizophreniform disorder, or schizophrenia. This is a problem as treatment and prognosis differ greatly for most of these diagnoses.

<span class="mw-page-title-main">Jim van Os</span> Dutch psychiatrist and epidemiologist

Jim van Os is a Dutch academic and psychiatrist. He is Professor of Psychiatry and medical manager of the Brain Center at Utrecht University Medical Center, the Netherlands.

Expressed emotion (EE), is a measure of the family environment that is based on how the relatives of a psychiatric patient spontaneously talk about the patient. It specifically measures three to five aspects of the family environment: the most important are critical comments, hostility, emotional over-involvement, with positivity and warmth sometimes also included as indications of a low-EE environment. The psychiatric measure of expressed emotion is distinct from the general notion of communicating emotion in interpersonal relationships, and from another psychological metric known as family emotional expressiveness.

Dr. Thomas McGlashan is an American professor of psychiatry at Yale University, well known for his academic contributions to the study of schizophrenia and other mental illnesses.

Dual diagnosis is the condition of having a mental illness and a comorbid substance use disorder. There is considerable debate surrounding the appropriateness of using a single category for a heterogeneous group of individuals with complex needs and a varied range of problems. The concept can be used broadly, for example depression and alcohol use disorder, or it can be restricted to specify severe mental illness and substance use disorder, or a person who has a milder mental illness and a drug dependency, such as panic disorder or generalized anxiety disorder and is dependent on opioids. Diagnosing a primary psychiatric illness in people who use substances is challenging as substance use disorder itself often induces psychiatric symptoms, thus making it necessary to differentiate between substance induced and pre-existing mental illness.

The management of schizophrenia usually involves many aspects including psychological, pharmacological, social, educational, and employment-related interventions directed to recovery, and reducing the impact of schizophrenia on quality of life, social functioning, and longevity.

In medicine, a prodrome is an early sign or symptom that often indicates the onset of a disease before more diagnostically specific signs and symptoms develop. It is derived from the Greek word prodromos, meaning "running before". Prodromes may be non-specific symptoms or, in a few instances, may clearly indicate a particular disease, such as the prodromal migraine aura.

<span class="mw-page-title-main">Region Hovedstadens Psykiatri</span> Hospital in capital region , Denmark

Region Hovedstadens Psykiatri is a psychiatric hospital with centers spread all around the capital region of Denmark, mainly consisting of Copenhagen, northern Zealand, and Bornholm.

Post-schizophrenic depression is a "depressive episode arising in the aftermath of a schizophrenic illness where some low-level schizophrenic symptoms may still be present." Someone that has post-schizophrenic depression experiences both symptoms of depression and can also continue showing mild symptoms of schizophrenia. Unfortunately, depression is a common symptom found in patients with schizophrenia and can fly under the radar for years before others become aware of its presence in a patient. However, very little research has been done on the subject, meaning there are few answers to how it should be systematically diagnosed, treated, or what course the illness will take. Some scientists would entirely deny the existence of post-schizophrenic depression, insisting it is a phase in schizophrenia as a whole. As of late, post-schizophrenic depression has become officially recognized as a syndrome and is considered a sub-type of schizophrenia.

<span class="mw-page-title-main">Persecutory delusion</span> Delusion involving perception of persecution

A persecutory delusion is a type of delusional condition in which the affected person believes that harm is going to occur to oneself by a persecutor, despite a clear lack of evidence. The person may believe that they are being targeted by an individual or a group of people. Persecution delusions are very diverse in terms of content and vary from the possible, although improbable, to the completely bizarre. The delusion can be found in various disorders, being more usual in psychotic disorders.

<span class="mw-page-title-main">Patrick McGorry</span> Australian psychiatrist

Patrick Dennistoun McGorry is an Irish-born Australian psychiatrist known for his development of the early intervention services for emerging mental disorders in young people.

Substance-induced psychosis is a form of psychosis that is attributed to substance intoxication. It is a psychosis that results from the effects of chemicals or drugs. Various psychoactive substances have been implicated in causing or worsening psychosis in users.

<span class="mw-page-title-main">Prognosis of schizophrenia</span>

The prognosis of schizophrenia is varied at the individual level. In general it has great human and economics costs. It results in a decreased life expectancy of 12–15 years primarily due to its association with obesity, little exercise, and smoking, while an increased rate of suicide plays a lesser role. These differences in life expectancy increased between the 1970s and 1990s, and between the 1990s and 2000s. This difference has not substantially changed in Finland for example – where there is a health system with open access to care.

The diagnosis of schizophrenia, a psychotic disorder, is based on criteria in either the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, or the World Health Organization's International Classification of Diseases (ICD). Clinical assessment of schizophrenia is carried out by a mental health professional based on observed behavior, reported experiences, and reports of others familiar with the person. Diagnosis is usually made by a psychiatrist. Associated symptoms occur along a continuum in the population and must reach a certain severity and level of impairment before a diagnosis is made. Schizophrenia has a prevalence rate of 0.3-0.7% in the United States

At risk mental state is the clinical presentation of those considered at risk of developing psychosis or schizophrenia. Such states were formerly considered treated as prodromes, emerging symptoms of psychosis, but this view is no longer prevalent as a prodromal period can not be confirmed unless the emergence of the condition has occurred.

Sex differences in schizophrenia are widely reported. Men and women exhibit different rates of incidence and prevalence, age at onset, symptom expression, course of illness, and response to treatment. Reviews of the literature suggest that understanding the implications of sex differences on schizophrenia may help inform individualized treatment and positively affect outcomes.

<span class="mw-page-title-main">Basic symptoms of schizophrenia</span> Subjective symptoms of schizophrenia

Basic symptoms of schizophrenia are subjective symptoms, described as experienced from a person's perspective, which show evidence of underlying psychopathology. Basic symptoms have generally been applied to the assessment of people who may be at risk to develop psychosis. Though basic symptoms are often disturbing for the person, problems generally do not become evident to others until the person is no longer able to cope with their basic symptoms. Basic symptoms are more specific to identifying people who exhibit signs of prodromal psychosis (prodrome) and are more likely to develop schizophrenia over other disorders related to psychosis. Schizophrenia is a psychotic disorder, but is not synonymous with psychosis. In the prodrome to psychosis, uncharacteristic basic symptoms develop first, followed by more characteristic basic symptoms and brief and self-limited psychotic-like symptoms, and finally the onset of psychosis. People who were assessed to be high risk according to the basic symptoms criteria have a 48.5% likelihood of progressing to psychosis. In 2015, the European Psychiatric Association issued guidance recommending the use of a subscale of basic symptoms, called the Cognitive Disturbances scale (COGDIS), in the assessment of psychosis risk in help-seeking psychiatric patients; in a meta-analysis, COGDIS was shown to be as predictive of transition to psychosis as the Ultra High Risk (UHR) criteria up to 2 years after assessment, and significantly more predictive thereafter. The basic symptoms measured by COGDIS, as well as those measured by another subscale, the Cognitive-Perceptive basic symptoms scale (COPER), are predictive of transition to schizophrenia.

References

  1. ↑ McGorry PD, Killackey EJ (2002). "Early intervention in psychosis: a new evidence based paradigm". Epidemiol Psychiatr Sci. 11 (4): 237–47. doi:10.1017/s1121189x00005807. PMID   12585014. S2CID   11005414.
  2. ↑ McGorry PD, Killackey E, Yung A (October 2008). "Early intervention in psychosis: concepts, evidence and future directions". World Psychiatry. 7 (3): 148–56. doi:10.1002/j.2051-5545.2008.tb00182.x. PMC   2559918 . PMID   18836582.
  3. ↑ Killackey E, Yung AR, McGorry PD (2007). "Early psychosis: where we've been, where we still have to go". Epidemiol Psychiatr Sci. 16 (2): 102–8. doi: 10.1017/S1121189X0000470X . PMID   17619539.
  4. ↑ "IRIS History of the development of EI in the UK". Archived from the original on 2012-08-03. Retrieved 2009-12-04.
  5. ↑ Joseph R, Birchwood M (September 2005). "The national policy reforms for mental health services and the story of early intervention services in the United Kingdom" (PDF). J Psychiatry Neurosci. 30 (5): 362–5. PMC   1197282 . PMID   16151542. Archived from the original (PDF) on 2015-11-17. Retrieved 2009-02-28.
  6. ↑ Birchwood M; Tood P; Jackson C (1988). "Early intervention in psychosis: the critical period hypothesis". British Journal of Psychiatry . Supplement 33 (33): 53–59. doi:10.1192/S0007125000297663. PMID   9764127. S2CID   32411917.
  7. ↑ Marshall M; Lewis S; Lockwood A; Drake R; Jones P; Croudace T (2005). "Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review". Arch Gen Psychiatry . 62 (9): 975–983. doi: 10.1001/archpsyc.62.9.975 . PMID   16143729.
  8. ↑ Edwards, J. & McGorry, P.D. (2002) (eds). Implementing Early Intervention in Psychosis. A guide to establishing early psychotic services. London. Martin Dunitz.
  9. 1 2 International Early Psychosis Association Writing Group (2005). "International clinical practice guidelines for early psychosis". British Journal of Psychiatry . Supplement 48: s120–s124. doi: 10.1192/bjp.187.48.s120 . PMID   16055801.
  10. ↑ Marshall M; Lockwood A; Lewis S; Fiander M (2004). "Essential elements of an early intervention service for psychosis: the opinions of expert clinicians". BMC Psychiatry . 4: 17. doi: 10.1186/1471-244X-4-17 . PMC   455683 . PMID   15230978.
  11. ↑ Camacho-Gomez M, Castellvi P. Effectiveness of family intervention for preventing relapse in first-episode psychosis until 24 months of follow-up: a systematic review with meta-analysis of randomized controlled trials [published online May 3, 2019]. Schizophr Bull. doi: https://doi.org/10.1093/schbul/sbz038
  12. ↑ Larsen TK; Friis S; Haahr U; Joa I; Johannessen JO; Melle I; Opjordsmoen S; Simonsen E; Vaglum P (2001). "Early detection and intervention in first-episode schizophrenia: a critical review". Acta Psychiatrica Scandinavica . 103 (5): 323–334. doi:10.1034/j.1600-0447.2001.00131.x. PMID   11380302. S2CID   24479187.
  13. ↑ Johannessen JO, McGlashan TH, Larsen TK, et al. (August 2001). "Early detection strategies for untreated first-episode psychosis". Schizophr. Res. 51 (1): 39–46. doi:10.1016/S0920-9964(01)00237-7. PMID   11479064. S2CID   7361138.
  14. 1 2 McGorry PD; Edwards J; Mihalopoulos C; Harrigan SM; Jackson HJ (1996). "EPPIC: an evolving system of early detection and optimal management". Schizophrenia Bulletin . 22 (2): 305–326. doi: 10.1093/schbul/22.2.305 . PMID   8782288.
  15. ↑ "Youth Access Team (YAT) Staff". Archived from the original on February 25, 2010. Retrieved 2009-02-14.
  16. 1 2 3 Petersen L; Nordentoft M; Jeppesen P; Ohlenschaeger J; Thorup A; Christensen TØ; Krarup G; Dahlstrøm J; Haastrup B; Jørgensen P (2005). "Improving 1-year outcome in first-episode psychosis: OPUS trial". British Journal of Psychiatry . 187 (Supplement 48): s98–s103. doi: 10.1192/bjp.187.48.s98 . PMID   16055817.
  17. 1 2 3 "TIPS webpage" . Retrieved 2009-02-14.
  18. ↑ Tait L; Lester H; Birchwood M; Freemantle N; Wilson S (2005). "Design of the BiRmingham Early Detection In untREated psyChosis Trial (REDIRECT): cluster randomised controlled trial of general practitioner education in detection of first episode psychosis [ISRCTN87898421]". BMC Health Services Research . 5 (1): 19. doi: 10.1186/1472-6963-5-19 . PMC   1082907 . PMID   15755321.
  19. ↑ Power P; Iacoponi E; Reynolds N; Fisher H; Russell M; Garety P; McGuire PK; Craig T (2007). "The Lambeth Early Onset Crisis Assessment Team Study: general practitioner education and access to an early detection team in first-episode psychosis". British Journal of Psychiatry . Supplement 51: s133–s139. doi: 10.1192/bjp.191.51.s133 . PMID   18055931.
  20. ↑ Srihari, Vinod H.; Jani, Anant; Gray, Muir (2016-02-01). "Early Intervention for Psychotic Disorders". JAMA Psychiatry. 73 (2): 101–2. doi:10.1001/jamapsychiatry.2015.2821. ISSN   2168-622X. PMID   26747524.
  21. ↑ Srihari, Vinod H.; Tek, Cenk; Pollard, Jessica; Zimmet, Suzannah; Keat, Jane; Cahill, John D.; Kucukgoncu, Suat; Walsh, Barbara C.; Li, Fangyong (2014-12-04). "Reducing the duration of untreated psychosis and its impact in the U.S.: the STEP-ED study". BMC Psychiatry. 14: 335. doi: 10.1186/s12888-014-0335-3 . ISSN   1471-244X. PMC   4262386 . PMID   25471062.
  22. ↑ Fusar-Poli, P, Rutigliano, G, Stahl, D, Davies, C, Bonoldi, I, Reilly, T, McGuire, P (2017). "Development and validation of a clinically based risk calculator for the transdiagnostic prediction of psychosis". JAMA Psychiatry. 74 (5): 493–500. doi:10.1001/jamapsychiatry.2017.0284. PMC   5470394 . PMID   28355424.
  23. ↑ Raket LL, Jaskolowski J, Kinon BJ, Brasen JC, Jönsson L, Wehnert A, Fusar-Poli P (2020). "Dynamic ElecTronic hEalth reCord deTection (DETECT) of individuals at risk of a first episode of psychosis: a case-control development and validation study". The Lancet Digital Health. 2 (5): e229–e239. doi: 10.1016/S2589-7500(20)30024-8 . PMID   33328055.
  24. ↑ "ORYGEN Youth Health". Archived from the original on 2009-10-24. Retrieved 2009-02-20.
  25. ↑ Yung AR, McGorry PD, McFarlane CA, Jackson HJ, Patton GC, Rakkar A (1996). "Monitoring and care of young people at incipient risk of psychosis". Schizophr Bull. 22 (2): 283–303. doi: 10.1093/schbul/22.2.283 . PMID   8782287.
  26. ↑ Broome MR, Woolley JB, Johns LC, et al. (August 2005). "Outreach and support in south London (OASIS): implementation of a clinical service for prodromal psychosis and the at risk mental state". Eur. Psychiatry. 20 (5–6): 372–8. doi:10.1016/j.eurpsy.2005.03.001. PMID   16171652. S2CID   27207646.
  27. ↑ Yale Medical School based clinic | PRIME
  28. ↑ Yung AR, Phillips LJ, Yuen HP, et al. (March 2003). "Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group". Schizophr. Res. 60 (1): 21–32. doi:10.1016/S0920-9964(02)00167-6. PMID   12505135. S2CID   31342026.
  29. ↑ McGorry PD, Yung AR, Phillips LJ, et al. (October 2002). "Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms". Arch. Gen. Psychiatry. 59 (10): 921–8. doi: 10.1001/archpsyc.59.10.921 . hdl: 10536/DRO/DU:30151296 . PMID   12365879.
  30. ↑ Morrison AP, French P, Parker S, et al. (May 2007). "Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk". Schizophr Bull. 33 (3): 682–7. doi:10.1093/schbul/sbl042. PMC   2526150 . PMID   16973786.
  31. ↑ Amminger; Schäfer; Papageorgiou; Harrigan; Cotton; McGorry; Berger (2008). "Indicated Prevention of Psychotic Disorders with Long-Chainomega-3 Fatty Acids: A Randomized, Placebo-Controlled Trial". Schizophrenia Research. 102 (1–3): 252. doi:10.1016/s0920-9964(08)70758-8. S2CID   53301111.
  32. ↑ Preti A, Cella M (2010). "Randomized-controlled trials in people at ultra high risk of psychosis: a review of treatment effectiveness". Schizophrenia Research. 123 (1): 30–36. doi:10.1016/j.schres.2010.07.026. PMID   20727717. S2CID   28017135.
  33. ↑ Jorm AF (2012). "Ethics of giving antipsychotic medication to at-risk young people". Australian and New Zealand Journal of Psychiatry. 46 (9): 908–909. doi:10.1177/0004867412455233. PMID   22802552. S2CID   206398433.
  34. ↑ Schultze-Lutter, F.; Michel, C.; Schmidt, S.J.; Schimmelmann, B.G.; Maric, N.P.; Salokangas, R.K.R.; Riecher-Rössler, A.; van der Gaag, M.; Nordentoft, M.; Raballo, A.; Meneghelli, A.; Marshall, M.; Morrison, A.; Ruhrmann, S.; Klosterkötter, J. (2015). "EPA guidance on the early detection of clinical high risk states of psychoses". European Psychiatry. 30 (3): 405–416. doi:10.1016/j.eurpsy.2015.01.010. ISSN   0924-9338. PMID   25735810. S2CID   20973529.
  35. ↑ Falloon I.R. (1992). "Early intervention for first episodes of schizophrenia: A preliminary exploration". Psychiatry. 55 (1): 4–15. doi:10.1080/00332747.1992.11024572. PMID   1557469.
  36. ↑ Johnstone EC; Crow TJ; Johnson AL; MacMillan JF (1986). "The Northwick Park Study of first episodes of schizophrenia. I. Presentation of the illness and problems relating to admission". British Journal of Psychiatry . 148 (2): 115–120. doi:10.1192/bjp.148.2.115. PMID   3697578. S2CID   31369353.
  37. ↑ Sensky T, Turkington D, Kingdon D, Scott JL, Scott J, Siddle R, O'Carroll M, Barnes TR (February 2000). "A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication". Arch. Gen. Psychiatry. 57 (2): 165–72. doi:10.1001/archpsyc.57.2.165. PMID   10665619.
  38. ↑ Kuipers E, Garety P, Fowler D, Dunn G, Bebbington P, Freeman D, Hadley C (October 1997). "London-East Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. I: effects of the treatment phase". Br J Psychiatry. 171 (4): 319–27. doi:10.1192/bjp.171.4.319. PMID   9373419. S2CID   38736138.
  39. ↑ Lewis S, Tarrier N, Haddock G, Bentall R, Kinderman P, Kingdon D, Siddle R, Drake R, Everitt J, Leadley K, Benn A, Grazebrook K, Haley C, Akhtar S, Davies L, Palmer S, Faragher B, Dunn G (September 2002). "Randomised controlled trial of cognitive-behavioural therapy in early schizophrenia: acute-phase outcomes". Br J Psychiatry Suppl. 43: s91–7. doi: 10.1192/bjp.181.43.s91 . PMID   12271807.
  40. 1 2 Department of Health. (2001) The mental health policy implementation guide. London: Department of Health.
  41. ↑ "Early Psychosis Declaration: An International Consensus Statement about Early Intervention and Recovery for Young People with Early Psychosis. Jointly issued by the World Health Organization and International Early Psychosis Association" (PDF). 28 September 2004.
  42. ↑ Bertolote J; McGorry P (2005). "Early intervention and recovery for young people with early psychosis: consensus statement". British Journal of Psychiatry . Supplement 48: s116–s119. doi: 10.1192/bjp.187.48.s116 . PMID   16055800.
  43. 1 2 Puntis, Stephen; Minichino, Amedeo; De Crescenzo, Franco; Harrison, Rachael; Cipriani, Andrea; Lennox, Belinda (2020-11-02). Cochrane Schizophrenia Group (ed.). "Specialised early intervention teams for recent-onset psychosis". Cochrane Database of Systematic Reviews. 2021 (2): CD013288. doi:10.1002/14651858.CD013288.pub2. PMC   8092671 . PMID   33135811.
  44. ↑ McCrone, P.; Knapp, M.; Dhanasiri, S. (2009). "Economic impact of services for first-episode psychosis: a decision model approach". Early Intervention in Psychiatry. 3 (4): 266–273. doi:10.1111/j.1751-7893.2009.00145.x. PMID   22642729. S2CID   30407696.
  45. ↑ Mihalopoulos C, McGorry PD, Carter RC (July 1999). "Is phase-specific, community-oriented treatment of early psychosis an economically viable method of improving outcome?". Acta Psychiatr Scand. 100 (1): 47–55. doi: 10.1111/j.1600-0447.1999.tb10913.x . PMID   10442439. S2CID   24815565.
  46. ↑ Aceituno, David; Vera, Norha; Prina, A. Matthew; McCrone, Paul (July 2019). "Cost-effectiveness of early intervention in psychosis: systematic review". The British Journal of Psychiatry. 215 (1): 388–394. doi: 10.1192/bjp.2018.298 . ISSN   0007-1250.
  47. ↑ Birchwood, unpublished.
  48. ↑ "Site disabled | orcmanage.unimelb.edu.au".
  49. ↑ "2011-12 Budget offers greater support for mental health patients | Prime Minister of Australia". Archived from the original on 2013-04-24. Retrieved 2013-04-13.
  50. ↑ Raven M. Evaluating evidence for Early Psychosis Prevention and Intervention Centres (EPPIC). The Conversation 2 Nov 2011 http://theconversation.com/evaluating-evidence-for-early-psychosis-prevention-and-intervention-centres-eppic-3604
  51. ↑ Amos A (2013). "An axeman in the cherry orchard: early intervention rhetoric distorts public policy". Aust N Z J Psychiatry. 47 (4): 317–320. doi:10.1177/0004867412471438. PMID   23568159. S2CID   8198295.
  52. ↑ Jorm AF (2013). "Do early intervention for psychosis services really save money?". Aust N Z J Psychiatry. 47 (4): 396–7. doi:10.1177/0004867412461959. PMID   23015749. S2CID   32272758.
  53. ↑ http://www.coag.gov.au/ "COAG Meeting 19th August 2011
  54. ↑ Center for National Policy, Washington DC; "What States Can Do:Reform Mental Health", August 8, 2012
  55. ↑ Blueprint for mental health service.
  56. ↑ "National Early Intervention Group - Aotearoa/New Zealand". www.earlypsychosis.org.nz. Archived from the original on 2006-05-06.
  57. ↑ Posselt, Christine Merrild; Albert, Nikolai; Nordentoft, Merete; Hjorthøj, Carsten (October 2021). "The Danish OPUS Early Intervention Services for First-Episode Psychosis: A Phase 4 Prospective Cohort Study With Comparison of Randomized Trial and Real-World Data". American Journal of Psychiatry . 178 (10): 941–951. doi:10.1176/appi.ajp.2021.20111596. ISSN   0002-953X.
  58. ↑ "OPUS er mindst lige så effektiv i den virkelige verden som i forsøgsperioden". www.psykiatri-regionh.dk (in Danish). Retrieved 2023-08-19.
  59. ↑ "Oregon Health Authority : Addictions and Mental Health Services : Addictions and Mental Health Services : State of Oregon".
  60. ↑ "What It Will Take to Make Coordinated Specialty Care Available to Anyone Experiencing Early Schizophrenia: Getting Over the Hump". PubMed Journals. Retrieved 2017-09-19.
  61. ↑ "NIMH » What is Coordinated Specialty Care (CSC)?". www.nimh.nih.gov. Retrieved 2017-09-19.
  62. ↑ Harrigan, S. M.; McGorry, P. D.; Krstev, H. (January 2003). "Does treatment delay in first-episode psychosis really matter?". Psychological Medicine. 33 (1): 97–110. doi:10.1017/s003329170200675x. ISSN   0033-2917. PMID   12537041. S2CID   202244541.
  63. ↑ Addington, J.; Van Mastrigt, S.; Addington, D. (February 2004). "Duration of untreated psychosis: impact on 2-year outcome". Psychological Medicine. 34 (2): 277–284. doi:10.1017/s0033291703001156. ISSN   0033-2917. PMID   14982133. S2CID   145714003.
  64. ↑ Wunderink, A.; Nienhuis, F. J.; Sytema, S.; Wiersma, D. (April 2006). "Treatment delay and response rate in first episode psychosis". Acta Psychiatrica Scandinavica. 113 (4): 332–339. doi:10.1111/j.1600-0447.2005.00685.x. ISSN   0001-690X. PMID   16638078. S2CID   1770126.
  65. ↑ Kane, John M.; Robinson, Delbert G.; Schooler, Nina R.; Mueser, Kim T.; Penn, David L.; Rosenheck, Robert A.; Addington, Jean; Brunette, Mary F.; Correll, Christoph U. (2016-04-01). "Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program". The American Journal of Psychiatry. 173 (4): 362–372. doi:10.1176/appi.ajp.2015.15050632. ISSN   1535-7228. PMC   4981493 . PMID   26481174.
  66. ↑ "Epip". Epip. Retrieved 2009-02-14.
  67. ↑ "「思覺失調」服務計劃". ha.org.hk. Retrieved 2009-02-14.
  68. ↑ "youth clinic". youthclinic.org. Retrieved 2009-02-14.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.